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Background: Short term dietary nitrate or nitrite supplementation has nitric oxide (NO)-mediated
beneﬁcial effects on blood pressure and inﬂammation and reduces mitochondrial oxygen consumption,
possibly preventing hypoxia. As these processes are implicated in atherogenesis, dietary nitrate was
hypothesized to prevent plaque initiation, hypoxia and inﬂammation.
Aims: Study prolonged nitrate supplementation on atherogenesis, hypoxia and inﬂammation in low
density lipoprotein receptor knockout mice (LDLr/).
Methods: LDLr/ mice were administered sodium-nitrate or equimolar sodium-chloride in drinking
water alongside a western-type diet for 14 weeks to induce atherosclerosis. Plasma nitrate, nitrite and
hemoglobin-bound nitric oxide were measured by chemiluminescence and electron parametric reso-
nance, respectively.
Results: Plasma nitrate levels were elevated after 14 weeks of nitrate supplementation (NaCl:
40.29 ± 2.985, NaNO3: 78.19 ± 6.837, p < 0.0001). However, prolonged dietary nitrate did not affect
systemic inﬂammation, hematopoiesis, erythropoiesis and plasma cholesterol levels, suggesting no se-
vere side effects. Surprisingly, neither blood pressure, nor atherogenesis were altered. Mechanistically,
plasma nitrate and nitrite were elevated after two weeks (NaCl: 1.0 ± 0.2114, NaNO3: 3.977 ± 0.7371,
p < 0.0001), but decreased over time (6, 10 and 14 weeks). Plasma nitrite levels even reached baseline
levels at 14 weeks (NaCl: 0.7188 ± 0.1072, NaNO3: 0.9723 ± 0.1279 p ¼ 0.12). Also hemoglobin-bound NO
levels were unaltered after 14 weeks. This compensation was not due to altered eNOS activity or con-
version into peroxynitrite and other RNI, suggesting reduced nitrite formation or enhanced nitrate/nitrite
clearance.
Conclusion: Prolonged dietary nitrate supplementation resulted in compensation of nitrite and NO levels
and did not affect atherogenesis or exert systemic side effects.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).dical Center, Department of
ity.nl (J.C. Sluimer).
Ireland Ltd. This is an open access1. Introduction
Ischemic heart disease and stroke remain the leading cause of
death in the western world [1]. Atherosclerosis presents the main
underlying cause of cardiovascular disease. Atherosclerosis is aarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
E. Marsch et al. / Atherosclerosis 245 (2016) 212e221 213lipid-driven inﬂammatory disease, initiated by endothelial
dysfunction, resulting in accumulation and subsequent oxidation of
cholesterol in the vessel wall. In turn, this triggers inﬂammatory
cell inﬁltration and macrophage foam cell formation leading to
apoptosis and secondary necrosis and plaque advancement [2].
Additionally, atherosclerotic plaques are hypoxic [3], with hypoxia
playing a causal role in atherogenesis by reducing macrophage
efferocytosis capacity [4]. In support, sleep apnea patients suffer
from an increased risk of atherosclerosis [5,6] and continuous
positive airway pressure-mediated oxygen supply in patients can
improve endothelial function [7].
Seeing this highly complex disease, we aimed to target athero-
sclerosis onmultiple levels: ameliorating hypertension, hypoxia and
inﬂammation. Inorganic dietary nitrate supplementation may pre-
sent such a multi-targeted approach, as it has been shown to
dampen several processes involved in atherosclerosis: hypertension,
hypoxia, endothelial dysfunction and inﬂammation. Short term di-
etary nitrate supplementation has been shown to lower resting
blood pressure in humans [8]. Furthermore, dietary nitrate supple-
mentation improves mitochondrial function, thereby reducing ox-
ygen requirement during exercise [9e11]. This reduced cellular
oxygen consumption may potentially restore plaque oxygenation
and alleviate plaque progression. Additionally, one week dietary
nitrate and nitrite supplementation reduced infarct size in a murine
myocardial ischemia-reperfusionmodel, by replenishing nitrate and
nitrite stores during infarction [12]. Also, dietary nitrate resulted in
enhanced cardiorespiratory function [13] and improved glucose
tolerance in diabetic rats [14]. Nitrate-rich beetroot juice intake prior
to exercise achieved similar results, in particular improving exercise
tolerance to high-intensity exercise [15], but also in patients with
chronic obstructive pulmonary disease [16]. Further, an anti-
inﬂammatory effect has been linked to dietary nitrate and nitrite
consumption [17], overall hinting towards an atherosclerosis-
protective role of dietary nitrate supplementation. Mechanistically,
nitrate is reduced to nitrite by commensal bacteria of the gastroin-
testinal tract and body surfaces [18]. The resulting nitrite can be
further reduced to NO via numerous pathways (reviewed in [19]). In
addition to the well-known vasodilatory and anti-hypertensive ac-
tion of NO [20,21], NO inhibition enhanced leukocyte rolling and
adhesion [22]. This suggests an anti-atherogenic leukocyte action of
NO itself. Also, NO production rate is decreased in atherosclerosis in
patients [23,24] which may contribute to the general pro-
inﬂammatory proﬁle and hampered vasodilatation seen in this
disease. Furthermore, nitrate supplementation via drinking water
reduced triglyceride levels, body weight gain and glucose intoler-
ance in endothelial nitric oxide synthase (eNOS) deﬁcient mice [25],
thus reversing symptoms of the metabolic syndrome. This suggests
also anti-atherosclerotic effects of nitrate.
Dietary nitrate supplementation has entered clinical trials in
cardiovascular disease, however, the results are variable [26e28].
Most human and murine studies have applied short nitrate sup-
plementation regimens ranging from 2-6 dayse15 days in humans,
reporting many health beneﬁts and improved functional perfor-
mance [10,29e31]. Additionally, conﬂicting evidence about possible
side-effects associated with long term nitrate supplementation [32]
has prompted us to study the effects of prolonged dietary nitrate
supplementation in hypercholesterolemic low density lipoprotein
receptor deﬁcient mice (LDLr/-). Based on the atheroprotective ef-
fects of nitrate described, we hypothesized that prolonged dietary
nitrate reverses plaque hypoxia, lowers hypertension and reduces
systemic inﬂammation, thereby alleviating plaque burden.
2. Methods
An expanded Methods section is available in the OnlineAppendix.
Low density lipoprotein receptor knockout (LDLr/-, n ¼ 15 per
group, 9 weeks of age) were fed a Western-type diet (WTD, 0.25%
cholesterol) for 14 weeks and received either sodium-nitrate
(NaNO3, 1 g/L) or equimolar sodium-chloride (NaCl) in drinking
water ad libitum. Blood pressure and heart rate were measured one
week prior to sacriﬁce by tailcuff method and PE-10 catheter in the
thoracic aorta. Plasma nitrate and nitrite were measured as
described earlier [33] and plasma hemoglobin-bound HbNO was
analyzed using electron parametric resonance.
2.1. Statistical analysis
All data are presented as mean ± SEM. All parameters were
analyzed using independent sample tests and were tested for
normal distribution using ShapiroeWilk normality test. Parameters
with two groups were compared with student's t-test or Man-
neWhitney rank-sum test. Correlations of plasma nitrate and ni-
trite levels with time of last nitrate consumption were tested using
Pearson or Spearman correlation (GraphPad Prism4).
3. Results
3.1. Dietary nitrate supplementation elevates plasma nitrate levels
First the effect of awestern-type diet (WTD) and equimolar NaCl
[34] on plasma nitrate levels was measured. Plasma nitrate con-
centrations were not affected by WTD with NaCl drinking
compared to normal drinking water plus a chow diet (Fig. 1A).
Dietary nitrate at a dose of 1 g/L is the most common dose
described to increase plasma nitrate levels, and corresponds to a
physiological nitrate intake achieved by a vegetable-rich diet in
humans [34]. Also in our hands,14weeks of dietary nitrate drinking
increased plasma nitrate levels compared to sodium drinking
controls (Fig. 1B), similarly to levels described [34]. No differences
were observed in body weight gain and liquid consumption sug-
gesting comparable eating and drinking behavior between groups
(Fig. 1C, D).
3.2. Prolonged dietary nitrate does not cause systemic side-effects
Dietary nitrate supplementation has been linked with tumori-
genesis. We therefore investigated the systemic effects of pro-
longed nitrate ingestion.
Morphologically, we did not observe organ tumor development,
as analyzed by a certiﬁed veterinary pathologist. Nitrates have also
recently been suggested to affect platelets and thrombosis [35].
However, neither total red blood cell count nor platelet count
(Fig. 2A) was affected by dietary nitrate supplementation. Addi-
tionally, red blood cell composition, as measured in red blood cell
mean cell volume (MCV), mean corpuscular hemoglobin (MCH) and
mean corpuscular hemoglobin concentration (MCHC) and hemat-
ocrit, did not differ between nitrate and NaCl treatments
(Fig. 2BeE). Together, these data suggest that neither hematopoi-
esis nor erythropoiesis were affected following prolonged dietary
nitrate supplementation.
Additionally, dietary nitrate and NO have been shown to reduce
circulating and adhering leukocytes [17,22,23,36,37]. Therefore, we
compared innate and adaptive immune cells in blood, spleen and
lymph nodes between nitrate supplemented mice and mice
receiving the control treatment. However, dietary nitrate supple-
mentation did not modulate circulating white blood cell count
(Fig. 3A) or differentiation and distribution of inﬂammatory cells in
blood or lymphoid organs (blood: Fig. 3BeH, Supplementary
Figure 1, spleen and lymph nodes: data not shown), suggesting
Fig. 1. Dietary nitrate supplementation elevates plasma nitrate levels. A. Plasma nitrate measured in LDLr/- mice drinking NaCl on WTD for 14 weeks as compared to mice with
normal drinking water on chow diet. B. Plasma nitrate levels in WTD-fed LDLr/- mice after drinking 1 g/L NaNO3 (black bars) or equimolar NaCl (white bars) for 14 weeks. ***p-
value<0.0001 NaNO3 vs. NaCl supplementation, student's t-test. C. Body weight and D. average liquid consumption per mouse per day in WTD-fed LDLr/- mice treated with NaCl or
NaNO3 for 14 weeks. Graphs represent mean ± SEM for 15 mice per group.
E. Marsch et al. / Atherosclerosis 245 (2016) 212e221214that prolonged dietary nitrate supplementation does not lower
circulating or tissue-resident immune cells.
3.3. Prolonged dietary nitrate supplementation does not affect
atherosclerosis development, hypoxia or blood pressure
Next, the effect of prolonged dietary nitrate supplementation on
atherosclerosis was studied. Short term dietary nitrate has been
shown to prevent microvascular inﬂammation in hypercholester-
olemic C57BL/6J mice, where it also reversed endothelial dysfunc-
tion [38]. However, LDLr/- mice receiving nitrate supplementationFig. 2. Prolonged dietary nitrate does not cause systemic side effects. A. Red blood cell conte
Coulter counter analysis of mean cell volume (MCV), C. mean corpuscular hemoglobin (MC
nitrate and NaCl drinking mice after 14 weeks of WTD. All data was analyzed using studenshowed similar plaque size and necrotic core development in the
aortic root as control (Fig. 4A), while plasma cholesterol and tri-
glyceride (TG) levels were unchanged (Fig. 5A,B). In line with this,
advanced plaques in a second location in the arterial tree, the aortic
arch (inner curvature and main branch points: brachiocephalic
trunk, left carotid artery, subclavian artery), also presented with
equal plaque size and necrotic core in NaNO3 and NaCl supple-
mented mice, as analyzed as the sum of all plaques in this area
(Fig. 4A) and as individual plaques in separate branch points (data
not shown). Additionally, macrophage content was equivalent be-
tween the nitrate and control group for both the aortic root andnt and platelet count after 14 weeks of nitrate supplementation compared to control. B.
H), D. mean corpuscular hemoglobin concentration (MCHC) and E. hematocrit level in
t's t-test.
Fig. 3. Prolonged dietary nitrate does not cause inﬂammatory side effects. A. White blood cell count (Coulter counter) in WTD-fed LDLr/- treated with NaCl or NaNO3 for 14 weeks.
B. FACS plot example for granulocyte and monocyte gating in NaCl and NaNO3 treated mice (see supplement for gating strategy). C. Absolute cell counts acquired by ﬂow cytometry
of granulocyte and D. monocyte content. E. Importantly for atherosclerosis, relative contribution of monocyte subsets with Ly6Chigh F. Ly6Clow and G. Ly6Cneg monocyte subsets. H.
Overview of remaining leucocyte subsets, which were all unchanged. Flow cytometry analysis was performed on whole blood of WTD-fed LDLr/- mice treated with NaCl or NaNO3
for 14 weeks. NaCl group is presented with white bars and NaNO3 group in black bars. Graphs represent mean ± SEM for 15 mice per group. All data was analyzed using student's t-
test.
E. Marsch et al. / Atherosclerosis 245 (2016) 212e221 215arch (Fig. 4B). Also, plaque collagen and smooth muscle cell content
did not change upon prolonged dietary nitrate supplementation
(Fig. 4C, D). This, together with unchanged cap thickness in both
groups (Fig. 4C) suggests no difference in plaque stability upon
dietary nitrate supplementation. In addition, blinded semi-
quantitative analysis of plaque phenotype (plaque ﬁbrosis, necro-
sis, granulocyte and adventitial immune cells) by a veterinary
pathologist did not reveal any changes (data not shown). In fact,
classiﬁcation of the aortic root plaque stage, as described earlier
[39], by a certiﬁed veterinary pathologist conﬁrmed similar plaque
progression (Fig. 4F). In short, plaques were classiﬁed in early le-
sions with fatty streaks containing only macrophage derived foam-
cells, intermediated lesions characterized by the additional pres-
ence of a collagenous cap and advanced lesions with involvement
of the media and increased collagen content. Prolonged dietary
nitrate supplementation hence did not alter plaque progression or
phenotype and did not affect macrophage tissue inﬁltration.
Additionally, we hypothesized that enhanced mitochondrial
function could reverse plaque hypoxia thereby alleviating plaque
burden. As shown previously [4], advanced murine plaques were
hypoxic, as measured using the hypoxia-speciﬁc markerpimonidazole. However, prolonged dietary nitrate did not affect
plaque hypoxia in the aortic root of mice having received either 14
weeks of nitrate or control onWTD (Fig. 4E). Oxygen sensitivity and
speciﬁcity of pimonidazole-mediated detection of tissue hypoxia
have been described elsewhere [4].
Moreover, we did not observe changes in blood pressure of long
term supplemented mice, as suggested by the literature. Neither
mean blood pressure, nor systolic or diastolic blood pressure was
affected by prolonged dietary nitrate, as measured by tailcuff
plethysmography and catheter probe in the carotid artery
(Fig. 5CeE). Also heart rate remained stable between groups
(Fig. 5F), suggesting no hemodynamic effects of prolonged dietary
nitrate supplementation. In conclusion, prolonged dietary supple-
mentation of nitrate does not alter atherosclerosis development,
tissue oxygenation or blood pressure.3.4. Prolonged nitrate drinking does not sustain increased nitrate-
nitrite-NO pathway
In order to understand the lack of effects seen, plasma nitrate
and nitrite levels were studied over time during dietary nitrate
Fig. 4. Prolonged dietary nitrate supplementation does not affect atherosclerosis development, hypoxia or blood pressure. A. Representative pictures and quantiﬁcations of H&Es
(hematoxylin & eosin) of aortic roots and arches, as well as B. MAC3 and staging of plaques of WTD-fed LDLr/- mice treated with NaCl or NaNO3 for 14 weeks. C. Sirius red
quantiﬁcation as well as cap thickness analysis, D. a-smooth muscle actin (aSMA), and E. Pimonidazole staining in aortic arches of WTD-fed LDLr/- mice treated with NaCl or NaNO3
for 14 weeks. F. Plaque stage scoring by a certiﬁed veterinary pathologist. White bars represent NaCl and black bars NaNO3 treated mice. Graphs represent mean ± SEM for 15 mice
per group and all data was analyzed using student's t-test.
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Fig. 5. Plasma lipid levels and hemodynamics are unaffected by prolonged dietary nitrate supplementation. A. Plasma cholesterol and B. plasma triglyceride (TG) levels in WTD-fed
LDLr/- mice treated with NaCl or NaNO3 for 14 weeks. C. Mean blood pressure (left panel), systolic (middle panel) and D. diastolic blood pressure, as measured by tailcuff
plethysmography in WTD-fed LDLR/- mice treated with NaCl or NaNO3 for 14 weeks. E. Mean arterial pressure, measured with a catheter probe in the carotid artery in NaNO3
compared to NaCl receiving mice after 14 weeks of WTD. F. Heart rate measured by tail-cuff method (left panel) and catheter probe (right panel) in the thoracic aorta in WTD-fed
LDLR/- mice treated with NaCl or NaNO3 for 14 weeks. White bars represent NaCl and black bars NaNO3 treated mice. Graphs represent mean ± SEM for 15 mice per group and all
data was analyzed using student's t-test.
E. Marsch et al. / Atherosclerosis 245 (2016) 212e221 217supplementation. Similarly to plasma nitrate, plasma nitrite levels
were not affected by WTD consumption and NaCl itself (Fig. 6A).
Two weeks dietary nitrate supplementation signiﬁcantly increased
plasma nitrite levels (Fig. 6B). However, over time and already after
6 weeks, plasma nitrite levels decrease gradually back to NaCl
control levels after 14 weeks of nitrate administration (Fig. 6B).
Also, plasma nitrate levels decrease similarly, but remain signiﬁ-
cantly elevated at 14 weeks (Fig. 6C). Hemoglobin-bound nitric
oxide levels were not elevated upon 14 weeks of dietary nitrate
supplementation (Fig. 6D, example of Electron Parametric Reso-
nance (EPR) spectrum in Fig. 6E). These data suggest a negative
feedback response to prolonged dietary nitrate supplementation.
Additionally, there was no correlation between plasma nitrate and
nitrite levels with the time point of last nitrate consumption. Three
hours after the last nitrate consumption, mice show equivalent
plasma nitrate levels compared to mice sacriﬁced at earlier time
points (Fig. 6F).
Mechanistically, compensation at the level of nitrite and NO
levels can be mediated by reduced nitrite and NO production by
bodily cells themselves or enhanced clearance of nitrate/nitrite
from the body. NO fate and production was studied in mice
receiving 14 weeks of dietary nitrate supplementation as follows:
We studied the citrulline/arginine ratio as a marker of NOS-
mediated conversion of arginine into citrulline and simultaneous
NO production. Additionally, the ratio of plasma ornithine/citrul-
line was used as a quantitative indicator of arginine consumption
by arginase [40]. Together these ratios provide an insight into NOS
activity as compared to arginase activity (see Fig. 6G). Both ratios
were unaffected (Fig. 6HeI), suggesting that NO production and
fate are not altered in mice receiving dietary nitrate. Furthermore,
the level of nitrotyrosine in plasmawas determined to estimate the
conversion of nitrite to peroxynitrite and other reactive nitrogenintermediates (RNI) [41]. Plasma nitrotyrosine levels were not
affected after 14 weeks of dietary nitrate (Fig. 6J) suggesting on the
one hand that compensation also does not take place at this level.
On the other hand, plasma tyrosine levels serve as amarker for liver
toxicity, which was also not affected by prolonged dietary nitrate
consumption. Overall, a slower compensation of plasma nitrate as
compared to plasma nitrite levels, might suggest initial compen-
sation at the plasma nitrite as opposed to the plasma nitrate level
(Fig. 6 BeC).4. Discussion
In this study, we show that short term dietary nitrate supple-
mentation increased plasma nitrate and nitrite levels, while
following prolonged dietary nitrate supplementation only plasma
nitrate levels remained slightly elevated. Plasma nitrite levels
decreased earlier than plasma nitrate levels, potentially hinting
towards a compensatory mechanism at the level of plasma nitrite.
Overall, fourteen weeks of dietary nitrate supplementation did not
affect blood pressure, systemic and tissue immune cells or
atherosclerosis development. These data suggest that elevated ni-
trate and nitrite in the initial 6 weeks of dietary nitrate supple-
mentation did either not exert anti-atherosclerotic effects on initial
fatty streak formation, ﬁrst occurring after 4e6weeks, or effects are
overridden upon subsequent plaque advancement. Also, the slight
elevation in plasma nitrate levels remaining after 14 weeks was not
sufﬁcient to affect plaque burden.
Short term dietary nitrate supplementation has been studied
extensively over the past few years. Effects described include blood
pressure lowering as well as anti-inﬂammatory effects after acute
or short term administration of dietary nitrate, as studied in in-
ﬂammatory bowel disease models [42,43]. Also, short term dietary
Fig. 6. Compensation of prolonged nitrate drinking does not involve eNOS activity and NO scavenging. A. Plasma nitrite after 14 weeks of NaCl drinking and WTD intervention
compared to normal water and chow diet exposed mice. B. Relative plasma nitrite and C. nitrate levels after 2, 6, 10 and 14 weeks of dietary nitrate supplementation. Data is
presented relative to control NaCl drinking mice of the same time point. D. Hemoglobin-bound nitric oxide levels in NaNO3 compared to NaCl supplemented mice after 14 weeks of
supplementation and WTD. E. Example of an Electron Parametric Resonance (EPR) spectrum showing Hb-NO detected in mouse blood of i) control mouse and ii) nitrate-exposed
mouse. With the arrows a small three line patterns is indicated with a g-factor of 2.05, representing HB-NO. F. Plasma nitrate (left panel) and nitrite (right panel) showed no
correlation with the time point of last nitrate consumption (Pearson correlation, GraphPad Prism4). G. Scheme of arginine metabolism. H. Plasma ornithine, citrulline and arginine
levels (left, middle and right panel, respectively) as well as I. calculated ornithine/citrulline and citrulline/arginine ratios (left and right panel, respectively). J. Plasma nitrotyrosine
levels to asses NO scavenging in mice drinking NaNO3 compared to NaCl for 14 weeks. Graphs represent mean ± SEM for 15 mice per group. ***p-value<0.0001 NaNO3 vs. NaCl
supplementation of same time point, student's t-test.
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E. Marsch et al. / Atherosclerosis 245 (2016) 212e221 219nitrate supplementation (max. of 12 days) was shown to reduce
erythropoiesis capacity in rats [44]. In this study we show that
upon long term nitrate supplementation, however, these proper-
ties, which were expected to be anti-atherosclerotic, are not
observed. Additionally, we do not ﬁnd any systemic side effects of
prolonged dietary nitrate supplementation.
Indeed, the main concern of nitrate supplementation used to be
cancer development, in particular stomach cancer, due to a reaction
of nitrite with dietary amines resulting in carcinogenic nitrosa-
mines. This has led to adjustments in policies of nitrate supple-
mentation in water and processed meat. More recent evidence
points at the many health beneﬁts of nitrate supplementation
[32,45,46], thereby changing the classic view on dietary nitrate
supplementation. In our model of prolonged dietary nitrate
administration, we did not observe organ tumor development. The
latter is not surprising as carcinogenesis with the modest level of
nitrate supplementation in the present study is unlikely. A dose of
1 g/L NaNO3 equals ca. 150 mmol nitrate per day based on observed
drinking behavior, similar to a vegetable rich diet in humans [34].
Dietary nitrate supplementation has entered clinical trials in
cardiovascular disease. However, the results are variable and few
long term studies have been performed so far in humans [26e28].
While using similar nitrate concentrations as used in our study,
beneﬁcial effects on oxygen cost during exercise, cardiovascular
function, blood pressure and inﬂammation have been described
upon short term interventions [8e11,13,15]. In fact, nitrate sup-
plementation periods of up to 4 weeks for humans and wild type
mice elevated both plasma nitrate and nitrite levels on the short
term [27,29]. In comparison, our data suggests a compensatory
negative feedback mechanism upon prolonged dietary nitrate
supplementation leading to normalization of plasma nitrite and NO
levels and eventually also plasma nitrate levels, over-riding the
effects observed following acute or short term dietary nitrate
supplementation. In accordance, Carlstr€om et al. have previously
described a return to baseline plasma and tissue nitrite levels after
8e10 weeks of prolonged nitrate drinking in mice and rats [25,47].
Also, recently Hezel et al. could conﬁrm a lack of plasma nitrite
and nitrate elevation upon 17 month of dietary nitrate supplemen-
tation [48]. Our results conﬁrm this ﬁnding and extend on the
compensatory mechanism. Carlstr€om et al. attribute the compen-
sation seen to a feedback down-regulation of eNOS activity in ro-
dents [47], as in addition to NO generation fromnitrate-nitrite, eNOS
generates NO from L-arginine. However, compensation was also
seen in eNOS deﬁcient mice and reduced NO production might
therefore not present the only mechanism [25]. In fact, in our hands
eNOS activity was probably not affected in mice as suggested by the
unaffected ratio of citrulline/arginine uponprolonged dietary nitrate
interventions, conﬁrming other compensatory mechanisms. Alter-
natively, enhanced clearance of nitrate and nitrite via urine could
explain the observed normalization in plasma nitrate and nitrite
concentrations after prolonged nitrate supplementation. Sixty to
seventy percent of the ingested dietary nitrate is secreted in the
urine as studied in rats and humans upon single high dose nitrate
supplementation [49,50]. Also, 24-h nitrate was enhanced in sub-
jects with elevated nitrate concentrations in drinking water,
compared to subjects drinking water with lower nitrate contami-
nation [51]. In fact, already after 7 days of dietary nitrate supple-
mentation increased urinary nitrate excretion by sevenfold [52].
Interestingly, Hezel et al. have investigated this upon 17months of
dietary nitrate supplementation and found inconclusive data due to
an extreme outlier in their data [48]. From the available data we
suggest that reduced nitrite could hence result from enhanced ni-
trate or nitrite urinary excretion. As we observed that plasma nitrite
reduction preceded plasma nitrate levels, we suggest the compen-
satory mechanism on the level of plasma nitrite and possibly NO.Additional explanations for nitrite compensation include
reduced nitrite generation from nitrate or enhanced conversion of
nitrite into NO and NO-derivedmetabolites. The latter is unlikely, as
we did not observe changes in plasma nitrotyrosine levels, a
biomarker for peroxynitrite generation and other RNI formations
[41]. These results conﬁrm the previously reported observation that
nitrate did not increase nitration of skeletal muscle proteins [9].
Additionally, we did not observe any harmful systemic side effects
of nitrate supplementation, such as atherosclerosis or plaque ne-
crosis, which would be expected when production of pro-
atherogenic RNI is increased [53,54]. This also suggests that the
prolonged dietary nitrate intervention is safe with respect to RNI-
induced disorders. Reduced nitrite generation from nitrate, how-
ever, might still present an additional compensatory mechanism. In
mammals, nitrate is reduced to nitrite by commensal bacteria only,
as mammals lack nitrate reductases themselves. Hendgen-Cotta
et al. did indeed show a reduction in plasma nitrite levels in mice
which received anti-septic mouth wash to reduce commensal
bacterial growth in addition to nitrate supplementation, compared
tomicewith sole dietary nitrate supplementation [34]. Also inmen,
Bondonno et al. could recently show that anti-bacterial mouth
wash reduces oral nitrate reduction [55], suggesting that changes in
the commensal ﬂora can affect nitrite and subsequent NO avail-
ability also in mice and men. However, if commensal bacterial
growth and productivity contributes to the compensation seen
upon prolonged nitrate drinking in mice, remains to be established.
Additionally, plasma nitrite can be derived from ceruloplasmin-
mediated oxidation or auto-oxidation of NO to nitrite (reviewed in
[19]). Nevertheless, similar hemoglobin-bound NO levels do not
support reduced auto-oxidation as an alternative compensatory
mechanism.
Overall, long term dietary nitrate supplementation does not
show beneﬁcial effects on atherosclerosis development in mice. If
prolonged dietary nitrate is also compensated for in humans re-
mains to be shown. Alternatively, intermittent therapy might pre-
sent a novel strategy and provide insights into the compensatory
mechanism. In fact, Carlstr€om et al. show a reversible down-
regulation of eNOS activity upon long term dietary nitrate [47].
However, a therapeutic effect of intermittent nitrate drinking re-
mains to be established, but could prove successful in humans,
based on the promising effects seen of short term dietary nitrate
supplementation.
5. Conclusion
There is still debate on potential beneﬁcial and detrimental ef-
fects of nitrate supplementation. In this manuscript, we show that
prolonged dietary nitrate supplementation abolished beneﬁcial
effects of nitrates, while at the same time not causing any systemic
side-effects in mice. Short term supplementation of dietary nitrates
might hence have therapeutic value, whereas chronic diseases,
such as atherosclerosis might not beneﬁt from continuous dietary
nitrate supplementation.
6. Signiﬁcance in the context of atherosclerosis
This study presents the evidence for a compensatory effect of
prolonged, continuous dietary nitrate supplementation. Addition-
ally, dietary nitrate supplementation was shown to be safe with
respect to cardiovascular outcomes, including blood pressure,
inﬂammation and atherosclerosis development.
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